Inhaled antibiotic for hospital-treated pneumonia
Part of Infections, Lungs & breathing clinical trials.
This study tests an inhaled antibiotic (lexofloxacin) compared to standard care for adults hospitalized with pneumonia. It aims to see if the inhaled treatment works as well or better and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are currently in the hospital.
- You have been diagnosed with pneumonia or have symptoms that strongly suggest it (like cough, fever, or trouble breathing).
- You have signs of infection, such as a fever, a high white blood cell count, or an elevated CRP blood test.
- You are not in septic shock and do not need more than 4 liters per minute of oxygen.
- You have not had a serious allergic reaction to fluoroquinolone antibiotics and do not have severe kidney problems.
- You are not pregnant and do not have a serious heart rhythm problem or a complicated lung infection (like an abscess).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This study watches how well the antibiotic lefamulin works in real-life patients with community-acquired pneumonia. It helps doctors understand the drug's safety and effectiveness outside of a controlled research setting.
This study tests whether a long-term antibiotic called moxifloxacin is safe and effective in reducing flare-ups for people with bronchiectasis (a lung condition that causes frequent infections). If you have had at least 2 flare-ups in the past year, this trial might help you manage your symptoms better.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.